The analysis of anti-UBQLN1 in different subgroup of validation cohort 1 indicated that it existed significant differences between early LC and advanced LC, NSCLC and SCLC, male and female LC patients. The gene discussed is UBQLN1; the disease is small cell lung carcinoma.